Yusuf Maulana, Ming-Heng Wu, Wei-Fan Chiang, Wei-Pin Hsiao, Ling-Cheng Mong, Wen-Chang Wang
{"title":"口腔疣状增生恶性转化的全基因组关联研究。","authors":"Yusuf Maulana, Ming-Heng Wu, Wei-Fan Chiang, Wei-Pin Hsiao, Ling-Cheng Mong, Wen-Chang Wang","doi":"10.1111/odi.70037","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>We conducted a genome-wide association study (GWAS) to identify single-nucleotide polymorphisms (SNPs) associated with malignant transformation in oral verrucous hyperplasia (OVH) patients.</p><p><strong>Methods: </strong>The genomic DNA used for SNP genotyping was extracted from the buffy coat. The primary trait of the GWAS was cancer-free survival, defined as beginning at the initial OVH diagnosis and ending at the first diagnosis of oral cancer, loss to follow-up, or the end of follow-up, whichever occurred first. For each SNP, the distributions of cancer-free survival were compared between minor allele carriers and non-carriers using the log-rank test, and an SNP with a significant difference was considered to be associated with OVH malignant transformation.</p><p><strong>Results: </strong>The GWAS identified seven genome-wide significantly associated SNPs (p < 10<sup>-7</sup>). Among them, four are located in long non-coding RNA genes (STX18-AS1, TARID, LOC124903183, and GNAO1-DT), two are located in protein-coding genes (LIMCH1 and ZBTB44), and the remaining one is located in a non-coding RNA gene (LOC105375416). For each SNP, the minor allele was associated with a higher risk of malignant transformation.</p><p><strong>Conclusions: </strong>This pilot GWAS suggests genetic contributions to OVH malignant transformation. These findings warrant validation in larger samples and replication across diverse populations in future studies.</p>","PeriodicalId":19615,"journal":{"name":"Oral diseases","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Pilot Genome-Wide Association Study of Malignant Transformation of Oral Verrucous Hyperplasia.\",\"authors\":\"Yusuf Maulana, Ming-Heng Wu, Wei-Fan Chiang, Wei-Pin Hsiao, Ling-Cheng Mong, Wen-Chang Wang\",\"doi\":\"10.1111/odi.70037\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>We conducted a genome-wide association study (GWAS) to identify single-nucleotide polymorphisms (SNPs) associated with malignant transformation in oral verrucous hyperplasia (OVH) patients.</p><p><strong>Methods: </strong>The genomic DNA used for SNP genotyping was extracted from the buffy coat. The primary trait of the GWAS was cancer-free survival, defined as beginning at the initial OVH diagnosis and ending at the first diagnosis of oral cancer, loss to follow-up, or the end of follow-up, whichever occurred first. For each SNP, the distributions of cancer-free survival were compared between minor allele carriers and non-carriers using the log-rank test, and an SNP with a significant difference was considered to be associated with OVH malignant transformation.</p><p><strong>Results: </strong>The GWAS identified seven genome-wide significantly associated SNPs (p < 10<sup>-7</sup>). Among them, four are located in long non-coding RNA genes (STX18-AS1, TARID, LOC124903183, and GNAO1-DT), two are located in protein-coding genes (LIMCH1 and ZBTB44), and the remaining one is located in a non-coding RNA gene (LOC105375416). For each SNP, the minor allele was associated with a higher risk of malignant transformation.</p><p><strong>Conclusions: </strong>This pilot GWAS suggests genetic contributions to OVH malignant transformation. These findings warrant validation in larger samples and replication across diverse populations in future studies.</p>\",\"PeriodicalId\":19615,\"journal\":{\"name\":\"Oral diseases\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-07-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oral diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/odi.70037\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"DENTISTRY, ORAL SURGERY & MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/odi.70037","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
A Pilot Genome-Wide Association Study of Malignant Transformation of Oral Verrucous Hyperplasia.
Objective: We conducted a genome-wide association study (GWAS) to identify single-nucleotide polymorphisms (SNPs) associated with malignant transformation in oral verrucous hyperplasia (OVH) patients.
Methods: The genomic DNA used for SNP genotyping was extracted from the buffy coat. The primary trait of the GWAS was cancer-free survival, defined as beginning at the initial OVH diagnosis and ending at the first diagnosis of oral cancer, loss to follow-up, or the end of follow-up, whichever occurred first. For each SNP, the distributions of cancer-free survival were compared between minor allele carriers and non-carriers using the log-rank test, and an SNP with a significant difference was considered to be associated with OVH malignant transformation.
Results: The GWAS identified seven genome-wide significantly associated SNPs (p < 10-7). Among them, four are located in long non-coding RNA genes (STX18-AS1, TARID, LOC124903183, and GNAO1-DT), two are located in protein-coding genes (LIMCH1 and ZBTB44), and the remaining one is located in a non-coding RNA gene (LOC105375416). For each SNP, the minor allele was associated with a higher risk of malignant transformation.
Conclusions: This pilot GWAS suggests genetic contributions to OVH malignant transformation. These findings warrant validation in larger samples and replication across diverse populations in future studies.
期刊介绍:
Oral Diseases is a multidisciplinary and international journal with a focus on head and neck disorders, edited by leaders in the field, Professor Giovanni Lodi (Editor-in-Chief, Milan, Italy), Professor Stefano Petti (Deputy Editor, Rome, Italy) and Associate Professor Gulshan Sunavala-Dossabhoy (Deputy Editor, Shreveport, LA, USA). The journal is pre-eminent in oral medicine. Oral Diseases specifically strives to link often-isolated areas of dentistry and medicine through broad-based scholarship that includes well-designed and controlled clinical research, analytical epidemiology, and the translation of basic science in pre-clinical studies. The journal typically publishes articles relevant to many related medical specialties including especially dermatology, gastroenterology, hematology, immunology, infectious diseases, neuropsychiatry, oncology and otolaryngology. The essential requirement is that all submitted research is hypothesis-driven, with significant positive and negative results both welcomed. Equal publication emphasis is placed on etiology, pathogenesis, diagnosis, prevention and treatment.